CheckRare

CheckRare

Latest Videos

Phase 2 Trial Evaluating LUM-201 for Treatment of Growth Hormone Deficiency
Phase 2 Trial Evaluating LUM-201 for Treatment of Growth Hormone Deficiency
Recent Advances In Treating Advanced Kidney Cancer
Recent Advances In Treating Advanced Kidney Cancer
Lafora Disease Explained
Lafora Disease Explained
Multi-Omic Databases and Rare Cancers
Multi-Omic Databases and Rare Cancers
Mitochondrial Myopathy
Mitochondrial Myopathy
What is Sturge-Weber Syndrome?
What is Sturge-Weber Syndrome?
Barth Syndrome Explained
Barth Syndrome Explained
VAMP2 Explained
VAMP2 Explained
This Patient with Sarcoidosis Was Misdiagnosed With Lung Cancer
This Patient with Sarcoidosis Was Misdiagnosed With Lung Cancer
Sarcoidosis Explained
Sarcoidosis Explained
Tatton Brown Rahman Syndrome
Tatton Brown Rahman Syndrome
Updates on Rozanolixizumab and Zilucoplan To Treat Myasthenia Gravis
Updates on Rozanolixizumab and Zilucoplan To Treat Myasthenia Gravis
Current Management of Persons with Myotonic Dystrophy Type 1
Current Management of Persons with Myotonic Dystrophy Type 1
New Treatments in Development for Fabry Disease
New Treatments in Development for Fabry Disease
Fabry Disease and Pain
Fabry Disease and Pain
The Pathophysiology of Galactosemia
The Pathophysiology of Galactosemia
CTCL Challenges of Treating People of Color Chapter 1
CTCL Challenges of Treating People of Color Chapter 1
Primary Mitochondrial Myopathy Explained
Primary Mitochondrial Myopathy Explained
Current Treatment Options for Children with Gaucher Disease Type 2
Current Treatment Options for Children with Gaucher Disease Type 2
CTCL Criteria to Diagnose Counsel Patients and Work-Up for Early-stage Mycosis Fungoides
CTCL Criteria to Diagnose Counsel Patients and Work-Up for Early-stage Mycosis Fungoides
Counseling Patients With T-Cell Dyscrasias Chapter 2
Counseling Patients With T-Cell Dyscrasias Chapter 2
Criteria to Diagnose Mycosis Fungoides Chapter 1
Criteria to Diagnose Mycosis Fungoides Chapter 1
Work Up for Early Stage Mycosis Fungoides Chapter 3
Work Up for Early Stage Mycosis Fungoides Chapter 3
Long Term Efficacy of Enzyme Replacement Therapy ERT in Gaucher Disease Type 1 and Type 3
Long Term Efficacy of Enzyme Replacement Therapy ERT in Gaucher Disease Type 1 and Type 3
Treating Gaucher Disease Type 3 A History Lesson
Treating Gaucher Disease Type 3 A History Lesson
Gaucher Disease Type 1 Type 2 and Type 3 Explained
Gaucher Disease Type 1 Type 2 and Type 3 Explained
Is It Safe to Participate in a Gene Therapy Clinical Trial?
Is It Safe to Participate in a Gene Therapy Clinical Trial?
Metachromatic Leukodystrophy Explained
Metachromatic Leukodystrophy Explained
Infantile-onset vs Late-onset Pompe Disease
Infantile-onset vs Late-onset Pompe Disease
Atacicept Shows Promise as IgA Nephropathy Treatment
Atacicept Shows Promise as IgA Nephropathy Treatment
Why a Clinical Hold Put on Gene Therapy for Fabry Disease
Why a Clinical Hold Put on Gene Therapy for Fabry Disease
Gene Therapy In Children With MPS I Showing Promise
Gene Therapy In Children With MPS I Showing Promise
Diagnosing Rett Syndrome
Diagnosing Rett Syndrome
Bardet-Biedl Syndrome Patient and His Parents Describe Their Diagnostic Journey
Bardet-Biedl Syndrome Patient and His Parents Describe Their Diagnostic Journey
What Is Autosomal Dominant Polycystic Kidney Disease ADPKD
What Is Autosomal Dominant Polycystic Kidney Disease ADPKD
Rett Syndrome Overview
Rett Syndrome Overview
Using Cryptocurrency To Develop Orphan Drugs for Rare Diseases
Using Cryptocurrency To Develop Orphan Drugs for Rare Diseases
Long-Term Efficacy of Daratumumab-Based Regimen in Multiple Myeloma
Long-Term Efficacy of Daratumumab-Based Regimen in Multiple Myeloma
Updated Data from CARTITUDE-1 and CARTITUDE-2 Studies Testing Cilta-Cel in RR Multiple Myeloma
Updated Data from CARTITUDE-1 and CARTITUDE-2 Studies Testing Cilta-Cel in RR Multiple Myeloma
How is AL Amyloidosis Currently Treated?
How is AL Amyloidosis Currently Treated?
Female Patients with Fabry Disease
Female Patients with Fabry Disease
Diagnosing Paroxysmal Nocturnal Hemoglobinuria PNH
Diagnosing Paroxysmal Nocturnal Hemoglobinuria PNH
Fabry Disease Treatment and Research Landscape
Fabry Disease Treatment and Research Landscape
Survival Benefit of Birtamimab in Treating AL Amyloidosis
Survival Benefit of Birtamimab in Treating AL Amyloidosis
Long-Term Efficacy and Safety of Cilta-Cel in Patients With RelapsedRefractory Multiple Myeloma
Long-Term Efficacy and Safety of Cilta-Cel in Patients With RelapsedRefractory Multiple Myeloma
Long Term Follow-Up With Ibrutinib + Venetoclax to Treat Chronic Lymphocytic Leukemia
Long Term Follow-Up With Ibrutinib + Venetoclax to Treat Chronic Lymphocytic Leukemia
Investigational Gene Therapy SRP-9001 Shows Promise in Duchenne Muscular Dystrophy Patients
Investigational Gene Therapy SRP-9001 Shows Promise in Duchenne Muscular Dystrophy Patients
Patient Reported Outcomes Supports Addition of Daratumumab in Multiple Myeloma Treatment
Patient Reported Outcomes Supports Addition of Daratumumab in Multiple Myeloma Treatment
How Homocystinuria Is Currently Treated
How Homocystinuria Is Currently Treated
Pathogenic TP53 Mutations Associated With Poor Prognosis in Pediatric AML
Pathogenic TP53 Mutations Associated With Poor Prognosis in Pediatric AML